HKPD NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares · Healthcare · Medical Distribution

Open interactive chart View report data Download investor PDF
Latest close 0.37 USD
-3.9% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -40.3% below the Trend Line and sits at 2.4% of its 52-week range. The latest completed week returned -3.9%, after a 1.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 49/100.

Setup score 27 out of 100
Latest Close 0.37 USD 24 Jul 2026
1W Return -3.9% latest completed week
4W Return 1.2% short-term follow-through
12W Return -46.7% quarterly tape
Trend Breadth 15.4% 8 of 52 weeks active
Volume Ratio 6.0x vs 13-week average
What is working
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -3.9% Latest completed week; four-week move 1.2%. Indicator stack 8/38 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 38.29% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 49/100 20 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -40.3% below the Trend Line and sits at 2.4% of its 52-week range. The latest completed week returned -3.9%, after a 1.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 6.0x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1212-week average 0.13

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.12Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 1.2% over four weeks, -46.7% over 12 weeks, and -72.3% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-3.9%
4W1.2%
12W-46.7%
26W-55.9%
52W-72.3%
Active trend streak0 weeks
Active weeks in one year8
Trend breadth15.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.63Latest activity-pressure read.
Pressure change-10.4%Four-week change in activity pressure.
Leadership-60.64Latest relative-leadership reading.
RS change7.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2025 Field coverage 88% Model confidence 72%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength58/100Blend of value, momentum, and quality. Underlying universe rank 43; rank 1 is best.
Value53/100Relative valuation strength. Underlying universe rank 48; rank 1 is best.
Quality51/100Profitability and accounting quality. Underlying universe rank 50; rank 1 is best.
Momentum53/100Medium-term price momentum. Underlying universe rank 48; rank 1 is best.
Growth53/100Revenue and earnings growth. Underlying universe rank 48; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework2/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.4x
Market value relative to trailing revenue.
EV / EBITDA
8.8x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
6.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
11.9%
Gross profit retained from each unit of revenue.
Operating margin
0.7%
Operating profit retained from revenue.
Free-cash-flow margin
3.6%
Free cash flow generated from revenue.
Return on invested capital
1.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-50.1%
Net share repurchases relative to market value.
Shareholder yield
-50.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment49/100

Weighted news tone is neutral across 20 relevant articles.

2 positive · 15 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-85.8%Distance below the 52-week high.
13-week volatility9.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher8 of 2618 weeks finished lower.
Best week+21.8%Week of 3 Jul.
Worst week-16.3%Week of 3 Apr.
Latest week-3.9%Week of 24 Jul.

Shape of recent returns

Strong gains6
Modest gains2
Flat weeks0
Modest losses7
Sharp losses11
Recent vol9.9%13-week weekly-return volatility.
Base vol12.0%52-week weekly-return volatility.
Up/down split18/34Count of positive and negative weeks in the 52-week window.
Average skew10.4% / -8.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape27/100

Trend, activity pressure, participation, and risk combine to a 27/100 tape read.

 Indicator analysis18/100

Latest 12-week confirmation: trend 0/12, activity pressure 4/12, relative leadership 0/12.

Activity pressure 0.12; No reversal markers Next-Week ExpectancyNegative 38.29%

Next-week expectancy is negative with a 38.29% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors53/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 96 SVQF2/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 715.0 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment49/100

Weighted news tone is neutral across 20 relevant articles.

Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) Cash Flow Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20260.37 USD-3.9%0.61 USD1.04 USD-0.63-60.6423.4MOff
17 Jul 20260.38 USD-15.6%0.63 USD1.05 USD-0.65-60.714.9MOff
10 Jul 20260.45 USD2.4%0.64 USD1.06 USD-0.65-56.55270.7KOff
3 Jul 20260.44 USD21.8%0.65 USD1.07 USD-0.68-57.83221.1KOff
26 Jun 20260.36 USD-8.6%0.66 USD1.08 USD-0.57-65.85435.0KOff
19 Jun 20260.40 USD-4.8%0.68 USD1.09 USD-0.33-65.24325.2KOff
12 Jun 20260.41 USD-16.1%0.70 USD1.10 USD-0.17-63.6014.3MOff
5 Jun 20260.49 USD-5.8%0.72 USD1.11 USD-0.08-56.82124.0KOff
29 May 20260.53 USD-0.9%0.75 USD1.11 USD0.01-57.61135.3KOff
22 May 20260.53 USD-0.0%0.77 USD1.12 USD0.12-56.73244.4KOff
15 May 20260.53 USD-14.8%0.80 USD1.13 USD0.19-56.906.5MOff
8 May 20260.62 USD-9.1%0.82 USD1.14 USD0.30-50.23116.4KOff
1 May 20260.69 USD6.3%0.84 USD1.15 USD0.17-42.8146.5KOff
24 Apr 20260.64 USD-11.7%0.86 USD1.15 USD-0.07-45.9875.1KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.